Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Per 10Q- The Company has received individual patient Expanded Access (compassionate use) requests for Brilacidin to treat critically ill COVID-19 patients who are not responding to prior therapy. Expanded Access was implemented by the FDA and Congress to address physician applications for access to potentially lifesaving drugs, prior to FDA approval, for patients in their care when available treatment options have failed. Following receipt of such requests, the Company has supplied Brilacidin to relevant hospitals for individual patient use, with the FDA granting the treating physician permission for the emergency administration of Brilacidin.
The Phase 2 COVID-19 clinical trial data as of the date of this Form 10-Q remains blinded to the Company. The Company’s biostatistics vendor is currently engaged in analyzing and computing study data and they are expected to deliver Topline results to the Company during the second week of November, 2021.
Topline results still on for this week.
They've shown to be very synergistic and now this trial would clinch it. I could see a Gilead offer.
I hope there's extra gravy.
Clock is counting down ipix news at anytime.
Feels like waiting on our reprieve call from the governor. Leo don't wait till 11:59, let the good news rip.
Amen brother. Success in moderate would help end the most severe cases.imo
Brilacidin has a stellar track record in past clinical trials.
Yes it's prerevenue with some skiddish investors and the ones who prey on that.
Thanks,, data lock just means no one can add or take away, when unblinded it's ready for all to view.
I believe the contacts have all been made and Leo has gone as far as he can prior to receiving data release. That email pretty much summed that up.
"We look forward to learning about our trial results anticipated to be unblinded and reported this week".
Very good to hear that. Many thanks for your effort today DrBones.
yep, thanks,,Seems B's MOA keeps growing.
Great read. I love these new findings. "heparin sulfate proteoglycans are found in number of viruses which means Brilaidin may be effective as an antiviral against more viral strains than previously thought".
Wow great work! Thanks.
Dr Degrado's study states that B binds to heparan sulfate proteoglycans (HSPGs) This result suggests that brilacidin has an additional mechanism of action by binding to HSPGs on the host cell, thereby blocking viral attachment. So not only does B disrupt the viral envelopes integrity it also binds to HSPGs leaving the virus to fail. Stopping the virus two ways. So more of B's MOA has been discovered and released. My take as I read the findings.
These viruses are responsible for the common cold. Nice to see B's robust response to them. A chest cold hospitalizes a lot of people. Many thanks Dr Bones for original posting.
This also from Reuters- Russia's daily COVID-19 death toll hits record high
https://news.yahoo.com/russias-daily-covid-19-death-080746509.html?fr=sycsrp_catchall
No after hours pr today. My theory is any news before Friday would likely be good news.. Keep checking those inboxes.
Yep what a coincidence..
Yep. We need cover hopefully Leo's holding the shotgun.
Then there's this "Study shows dramatic decline in effectiveness of all three COVID-19 vaccines over time"
Phizer is the real insider. Go little B make us proud.
https://www.yahoo.com/news/study-shows-dramatic-decline-effectiveness-025801001.html
Pr said Week of the eighth.
That big Phizer covid banner called today's action.
Good news will get us firm footing and a big sigh of relief.
I added 5000 @.33. The Phizer covid news cut us down but I figure we have a drug for multiple maladies. Hoping for trial success that's for sure.
We just need our trial to be successful with that I believe everything else will take care of itself. We have an effective compound that's had success against multiple diseases. I figure Leo is in talks right now. Let's see what next week brings.
Yeah would be nice to hear some scientific thought especially from someone more neutral when comparing this trial to ABSSSI single dose success. I own shares so I'm very bias toward success some don't own shares and they may have there own negative biases. KMBJN I believe is a straight shooter.
Brilacidin strong pedigree with successful clinical trials already under it's belt. Looking for noted improvement in the moderate patients we'll soon find out. Go B
Go B. Results coming. SI 426
Last count 730,000 shares. Movin on up!
Like it or not it's still in the WSJ. Like!
There will be crow for others.
This formulation was developed for UC. B was found to have a low absorption rate but still some systemic absorption happening. I've wondered if a B formula could be developed that would boost absorbancy.
It's Rem plus saline placebo compared to Rem plus B. I smell success. Go B
10-4. Thanks
My thought also. Brilacidin has the potential for use against many other malady's so I see covid success as a massive springboard from here.
Reality is 10q said there has been no selling.
Insignificant it's a new day.
.50's breaks 52 week high. Next on tap.
Bahahahaha upward hard and fast as we shoot the moon. Go Leo